Arcus BiosciencesRCUS
紐約證券 · USD
28.40
-0.66
(-2.27%)
盤中 09/10 03:47 (UTC+8)
09/10 03:47 (UTC+8)
Arcus BiosciencesRCUS
28.40
-0.66
(-2.27%)
財務數據
損益表
- 1.45
- 0.39
- 0.48
- 0.26
- 0.28
- 1.60
- 0.26
- 0.33
- 0.17
- 0.41
- 367.74
- -73.10
- 23.08
- -45.83
- 7.69
- 471.43
- -83.75
- 26.92
- -48.48
- 141.18
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 41,000 | 17,000 | 33,000 | 26,000 | 160,000 | 28,000 | 26,000 | 48,000 | 39,000 | 145,000 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 41,000 | 17,000 | 33,000 | 26,000 | 160,000 | 28,000 | 26,000 | 48,000 | 39,000 | 145,000 |
營業費用 | 137,000 | 151,000 | 147,000 | 168,000 | 168,000 | - | - | - | 145,000 | 161,000 |
研發費用 | 113,000 | 122,000 | 121,000 | 141,000 | 139,000 | 122,000 | 101,000 | 123,000 | 115,000 | 109,000 |
推銷及管理費用 | 24,000 | 29,000 | 26,000 | 27,000 | 29,000 | 28,000 | 28,000 | 30,000 | 30,000 | 32,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | 20,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -96,000 | -134,000 | -114,000 | -142,000 | -8,000 | -122,000 | -103,000 | -105,000 | -106,000 | -16,000 |
其他收入及費用 | 8,000 | 9,000 | 10,000 | 10,000 | 10,000 | 11,000 | 12,000 | 15,000 | 12,000 | 12,000 |
利息費用 | 3,000 | 3,000 | 2,000 | 3,000 | 2,000 | 1,000 | 2,000 | 2,000 | -1,000 | - |
稅前純益 | -91,000 | -128,000 | -106,000 | -135,000 | - | -112,000 | -93,000 | -92,000 | -93,000 | -4,000 |
所得稅 | - | - | - | - | - | - | 1,000 | - | - | - |
稅後純益 | -91,000 | -128,000 | -106,000 | -135,000 | - | -112,000 | -94,000 | -92,000 | -93,000 | -4,000 |
基本每股稅後盈餘(元) | -0.72 | -1.02 | -0.89 | -1.27 | - | -1.14 | -1.03 | -1.00 | -1.02 | -0.05 |
稀釋每股稅後盈餘(元) | -0.72 | -1.02 | -0.90 | -1.30 | 0.05 | -1.14 | -1.03 | -1.02 | -1.04 | -0.05 |
基本平均股數(千股) | 126100.00 | 125400.00 | 118500.00 | 106500.00 | 106100.00 | 98400.00 | 91700.00 | 91400.00 | 91100.00 | 86200.00 |
稀釋平均股數(千股) | 126100.00 | 125400.00 | 118500.00 | 106500.00 | 106500.00 | 98400.00 | 91700.00 | 91400.00 | 91100.00 | 86200.00 |
還原基本每股稅後盈餘(元) | -0.72 | -1.02 | -0.89 | -1.27 | - | -1.14 | -1.03 | -1.00 | -1.02 | -0.05 |
還原稀釋每股稅後盈餘(元) | -0.72 | -1.02 | -0.90 | -1.30 | 0.05 | -1.14 | -1.03 | -1.02 | -1.04 | -0.05 |
還原基本平均股數(千股) | 126,100 | 125,400 | 118,500 | 106,500 | 106,100 | 98,400 | 91,700 | 91,400 | 91,100 | 86,200 |
還原稀釋平均股數(千股) | 126,100 | 125,400 | 118,500 | 106,500 | 106,500 | 98,400 | 91,700 | 91,400 | 91,100 | 86,200 |
EBITDA(千元) | -87,000 | -126,000 | -104,000 | -133,000 | 1,000 | -112,000 | -94,000 | -94,000 | -99,000 | -7,000 |